These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 26070557)
1. Polo-like Kinase 1 (Plk1) Up-regulates Telomerase Activity by Affecting Human Telomerase Reverse Transcriptase (hTERT) Stability. Huang Y; Sun L; Liu N; Wei Q; Jiang L; Tong X; Ye X J Biol Chem; 2015 Jul; 290(30):18865-73. PubMed ID: 26070557 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Kim JH; Park SM; Kang MR; Oh SY; Lee TH; Muller MT; Chung IK Genes Dev; 2005 Apr; 19(7):776-81. PubMed ID: 15805468 [TBL] [Abstract][Full Text] [Related]
3. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Atkinson SP; Hoare SF; Glasspool RM; Keith WN Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide down-regulates polo-like kinase 1 through a proximal promoter cell cycle gene homology region. Zhang J; Wang S; Kern S; Cui X; Danner RL J Biol Chem; 2007 Jan; 282(2):1003-9. PubMed ID: 17121839 [TBL] [Abstract][Full Text] [Related]
5. Plk1-mediated mitotic phosphorylation of PinX1 regulates its stability. Wang C; Yu J; Yuan K; Lan J; Jin C; Huang H Eur J Cell Biol; 2010 Oct; 89(10):748-56. PubMed ID: 20573420 [TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase is a novel target of Hippo-YAP pathway. Zhang Q; Liu N; Bai J; Zhou Q; Mao J; Xu L; Liu J; Wei H; Ren C; Wu X; Wang M; Zhao B; Cong YS FASEB J; 2020 Mar; 34(3):4178-4188. PubMed ID: 31950551 [TBL] [Abstract][Full Text] [Related]
7. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma. Kunisada M; Budiyanto A; Bito T; Nishigori C; Ueda M Br J Dermatol; 2005 Mar; 152(3):435-43. PubMed ID: 15787811 [TBL] [Abstract][Full Text] [Related]
9. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. Kawauchi K; Ihjima K; Yamada O J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522 [TBL] [Abstract][Full Text] [Related]
10. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188 [TBL] [Abstract][Full Text] [Related]
11. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Kreis NN; Sommer K; Sanhaji M; Krämer A; Matthess Y; Kaufmann M; Strebhardt K; Yuan J Cell Cycle; 2009 Feb; 8(3):460-72. PubMed ID: 19177004 [TBL] [Abstract][Full Text] [Related]
12. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Takakura M; Kyo S; Inoue M; Wright WE; Shay JW Mol Cell Biol; 2005 Sep; 25(18):8037-43. PubMed ID: 16135795 [TBL] [Abstract][Full Text] [Related]
13. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer. Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386 [TBL] [Abstract][Full Text] [Related]
14. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Yang H; Ou CC; Feldman RI; Nicosia SV; Kruk PA; Cheng JQ Cancer Res; 2004 Jan; 64(2):463-7. PubMed ID: 14744757 [TBL] [Abstract][Full Text] [Related]
15. G Giráldez S; Galindo-Moreno M; Limón-Mortés MC; Rivas AC; Herrero-Ruiz J; Mora-Santos M; Sáez C; Japón MÁ; Tortolero M; Romero F FASEB J; 2017 Jul; 31(7):2925-2936. PubMed ID: 28360195 [TBL] [Abstract][Full Text] [Related]
16. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
17. Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition. Lange L; Hemmerich P; Spänkuch B Oncotarget; 2015 Sep; 6(28):25801-14. PubMed ID: 26317649 [TBL] [Abstract][Full Text] [Related]
18. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Guilleret I; Benhattar J Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633 [TBL] [Abstract][Full Text] [Related]
19. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Kimura A; Ohmichi M; Kawagoe J; Kyo S; Mabuchi S; Takahashi T; Ohshima C; Arimoto-Ishida E; Nishio Y; Inoue M; Kurachi H; Tasaka K; Murata Y Oncogene; 2004 Jun; 23(26):4505-15. PubMed ID: 15048073 [TBL] [Abstract][Full Text] [Related]
20. A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1. Akdeli N; Riemann K; Westphal J; Hess J; Siffert W; Bachmann HS Mol Cancer; 2014 Apr; 13():87. PubMed ID: 24767679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]